Company: ARVN
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001655759-25-000147
Chunk: 1

Company: ARVINAS, INC.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure.

On September 17, 2025, the Company issued a press release providing an update on its collaboration with Pfizer, Inc. (“ Pfizer”) and announcing further actions to support value creation. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 8.01 Other Events.